SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
87.84 +1.49  +1.73% NYSE Arca Apr 26, 16:58 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -2.54% -2.53% 0.61% 88
3M -9.44% -9.49% -6.66% 77
6M 4.31% 4.14% 2.39% 31
YTD 1.81% 1.76% 1.22% 29
1Y 22.72% 22.50% 13.88% 15
3Y 3.84% 3.79% 2.01% 37
5Y 20.15% 20.13% 13.79% 9
10Y 16.92% 16.91% 12.96% 5
As of April 25, 2018. Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.00% 0.00% 0.00%
Stock 99.94% 99.94% 0.00%
Bond 0.06% 0.06% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of April 24, 2018

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of April 24, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of April 24, 2018

XBI Stock Market Capitalization

Giant 3.93%
Large 7.96%
Medium 26.16%
Small 52.59%
Micro 9.36%
As of April 24, 2018

XBI Stock Style Exposure

Large Cap Value 4.32%
Large Cap Blend 0.00%
Large Cap Growth 8.01%
Mid Cap Value 0.00%
Mid Cap Blend 2.78%
Mid Cap Growth 24.34%
Small Cap Value 0.34%
Small Cap Blend 19.63%
Small Cap Growth 40.58%
As of April 24, 2018
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
AVXS AveXis Inc 2.35% 212.99 +0.24%
ONCE Spark Therapeutics Inc 1.87% 77.08 +4.40%
SRPT Sarepta Therapeutics Inc 1.57% 78.90 +1.41%
ICPT Intercept Pharmaceuticals Inc 1.57% 70.10 +5.97%
LOXO Loxo Oncology Inc 1.54% 132.86 +0.23%
AGIO Agios Pharmaceuticals Inc 1.53% 85.47 +1.29%
BMRN Biomarin Pharmaceutical Inc 1.48% 82.50 +1.19%
CELG Celgene Corp 1.47% 92.07 +3.22%
ADMS Adamas Pharmaceuticals Inc 1.46% 29.32 +3.09%
UTHR United Therapeutics Corp 1.46% 110.73 +0.87%
As of April 24, 2018
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Small Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 3.17 yrs
Michael Feehily 6.17 yrs
Raymond Donofrio 0.99 yrs

XBI Net Fund Flows

1M 344.70M
3M 641.02M
6M 669.60M
YTD 641.02M
1Y 1.089B
3Y 2.131B
5Y 2.544B
10Y 2.888B
As of March 31, 2018

XBI Risk Info

Beta (5Y) 1.537
Max Drawdown (All) 49.25%
Historical Sharpe (10Y) 0.7908
Historical Sortino (All) 1.011
30-Day Rolling Volatility 33.35%
Daily Value at Risk (VaR) 1% (All) 4.88%
Monthly Value at Risk (VaR) 1% (All) 21.11%

XBI Fundamentals

Dividend Yield TTM (4-26-18) 0.27%
SEC Yield (4-24-18) 0.29%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.249
Weighted Average Price to Book Ratio 5.729
Weighted Median ROE -25.31%
Weighted Median ROA -26.68%
Forecasted Dividend Yield 0.13%
Forecasted PE Ratio 18.36
Forecasted Price to Sales Ratio 5.191
Forecasted Price to Book Ratio 4.216
Number of Holdings 117
As of April 24, 2018

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 20.26%
Forecasted Book Value Growth 5.73%
Forecasted Cash Flow Growth 11.64%
Forecasted Earnings Growth 18.99%
Forecasted Revenue Growth 15.64%
As of April 24, 2018

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Termination Date
Last Annual Report Date 6/30/2017
Last Prospectus Date 10/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.